Overview

Phase II Avastin Trial for Stage IIIB/IV NSCLC

Status:
Terminated

Trial end date:
2012-04-01

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label, multicenter study in 160 patients in first line treatment and 114 in second line treatment with advanced or metastatic NSCLC (Stage IIIB/IV).

Phase:

Phase 2

Details

Lead Sponsor:

Pharmatech

Collaborators:

Genentech, Inc.
Sanofi

Treatments:

Bevacizumab
Carboplatin
Docetaxel